ALFA FinderNSE filing, NSE: ANTHEM. Summary written from the filing by ALFA Finder's alert engine.
Anthem Biosciences Ltd: key numbers
- Share price
- ₹951.15
- Market cap
- ₹53,568 Cr
- Revenue (annual)
- ₹2,124 Cr
- Net profit (annual)
- ₹591.8 Cr
- P/E (TTM)
- 87.2×Sector 43.8×
- Promoter holding
- 71.40%-0.02% QoQ
- FII holding
- 3.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anthem Biosciences Ltd
All →Anthem Biosciences Earnings Call Transcript: Key Takeaways
Anthem delivered robust Q2 results driven by CRDMO business and sharp margin expansion. Management highlighted strong operating leverage and cost discipline while scaling capacity.
- Call
- Guides 10% growth
Anthem Biosciences Investor Presentation: Key Takeaways
Q2FY27 revenue ₹5,940 Mn (+7.9% YoY), PAT ₹2,115 Mn (+21.9%), EBITDA margin 50.6% including ₹589 Mn other income. H1FY27 revenue fell 7.2%.
Anthem Biosciences Results Update
Anthem Biosciences reported Q2 FY27 consolidated revenue of ₹5,940 Mn, up 7.9% year-on-year, and PAT of ₹2,115 Mn. H1 FY27 PAT rose 7.2% to ₹3,314 Mn.
Anthem Biosciences Q2 FY27 Results: Net Profit ₹211.5 Cr, Up 22.0% YoY
Anthem Biosciences Ltd reported revenue from operations of ₹594 Cr (+7.9% YoY) and net profit of ₹211.5 Cr (+22.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹211.5 Cr · +22.0% YoY
Anthem Biosciences Board Meeting Date
Anthem Biosciences scheduled a Board meeting for November 3, 2026 to approve Q1 and H1 FY27 financial results. The trading window remains closed until November 5, 2026.
Anthem Biosciences Other Announcement
Anthem Biosciences Ltd has submitted its quarterly shareholding pattern as per SEBI regulations. The filing provides the current distribution of promoter and public shareholdings.
Other employee stock options announcements
All →Axis Bank Employee Stock Options
Axis Bank allotted 220,144 equity shares on November 11, 2026, under its ESOP/RSU scheme. The paid-up capital increased, with no cash value stated for the allotment.
Regency Fincorp Employee Stock Options
Regency Fincorp instituted ESOP 2026, granting a pool of 1 crore employee stock options. Each option converts into one equity share at a market-linked exercise price.
- Execution
- Exercise period of up to 10 years from each vesting date
eClerx Services Employee Stock Options
eClerx's Employee Welfare Trust bought 11,825 shares and sold 11,059 shares on NSE on 6 and 9 November 2026. Net holding moved only slightly, from 2.49% to 2.48%.
- Value
- ₹1.89 Cr
Virtuoso Optoelectronics Employee Stock Options
Virtuoso Optoelectronics granted up to 4,40,000 options under ESOP 2023 at up to Rs 468.55 each. Nomination and Remuneration Committee approved the grant on 10 November 2026.
Stove Kraft Employee Stock Options
Stove Kraft granted 97,519 stock options to eligible employees under its ESOP Plan 2018 at ₹789.35 per option. The grant vests over four years, with no cash proceeds received at grant.
- Execution
- Vesting over 4 years: 10% at 1st anniversary, 20% at 2nd, 30% at 3rd, 40% at 4th; exercisable within 4 years of vesting.
RBL Bank Employee Stock Options
RBL Bank allotted 1,85,172 equity shares to employees on 9 November 2026 on exercise of vested ESOPs. Paid-up capital rises to Rs 1,552.99 Crore.